Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer.
about
Functional roles of Speckle-Type Poz (SPOP) Protein in Genomic stabilityFBP1 loss contributes to BET inhibitors resistance by undermining c-Myc expression in pancreatic ductal adenocarcinomaHDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression
P2860
Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Dual inhibition of AKT-mTOR an ...... SPOP-mutated prostate cancer.
@en
Dual inhibition of AKT-mTOR an ...... SPOP-mutated prostate cancer.
@nl
type
label
Dual inhibition of AKT-mTOR an ...... SPOP-mutated prostate cancer.
@en
Dual inhibition of AKT-mTOR an ...... SPOP-mutated prostate cancer.
@nl
prefLabel
Dual inhibition of AKT-mTOR an ...... SPOP-mutated prostate cancer.
@en
Dual inhibition of AKT-mTOR an ...... SPOP-mutated prostate cancer.
@nl
P2093
P2860
P50
P356
P1476
Dual inhibition of AKT-mTOR an ...... r SPOP-mutated prostate cancer
@en
P2093
Jennifer J Westendorf
Junhui Chen
Liguo Wang
R Jeffrey Karnes
Saravut John Weroha
Shangqian Wang
P2860
P356
10.15252/EMMM.201708478
P577
2018-04-01T00:00:00Z